An exhibit in the lobby of Green Library’s east wing titled “Undergraduate Showcase: The Senior Reflection in Biology” presented capstone projects on biology and life sciences throughout the 2026 ...
Gil Efron to Step Down as CEO in August 2026 for Health Considerations; Will Continue to Lead Corporate Development REHOVOT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (NASDAQ/TASE ...
Newspoint on MSN
Indian Navy Agniveer recruitment: An opportunity to become an Agniveer in the Indian Navy, find out when the application process begins
Major news has emerged for young aspirants dreaming of a career in the Indian Navy. The Navy has invited applications for recruitment to various posts under the Agneepath Scheme for the year 2027.
Exciting Opportunities in the Indian Navy A significant announcement has been made for aspiring candidates looking to join the Indian Navy. Applications are now open for various roles under the ...
The biotech industry has delivered an upbeat performance so far in 2026 despite an uncertain macroeconomic backdrop. Strong fourth-quarter results, better visibility, new drug approvals and ...
Janus Henderson Global Life Sciences Fund returned 18.66% and the MSCI World Health Care Index SM returned 10.60%.
For most science students, it can seem that there are only two paths open after one earns a Ph.D. — being a professor or working in a privately-funded lab. Regardless, this confines scientists to a ...
LOS ANGELES, CA / ACCESS Newswire / March 12, 2026 / Today, eXoZymes Inc. ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel ...
ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
Rapid Micro Biosystems, Inc. sees strong FY25 revenue growth from Growth Direct placements, but losses persist. Click for more on RPID Q4 earnings results.
NervGen Pharma Corp. ("NervGen" or the "Company") , a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results